 |
|
|
| |
Comparison of Asians vs. Non-Asians treated with TDF Plus Peginterferon (PEG)
|
| |
| |
Reported by Jules Levin
25th Conference of the Asian Pacific Association for the Study of the Liver, 20-24 February 2016, Tokyo, Japan
WY Tak1, SH Ahn 2, OTY Tsang3, AJ Hui4, X Ma5, WL Chuang6, SG Lim7, R Mehta8, EB Martins9, LJ Yee9, P Dinh9, L Lin9, P Charuworn9, GM Subramanian9, S Fung10, M Elkashab11, H Trinh12, HLY Chan13, P Marcellin14
1Kyungpook National University Hospital, Daegu, South Korea; 2Yonsei University College of Medicine, Seoul, South Korea;
3Princess Margaret Hospital, Hong Kong; 4Alice Ho Miu Ling Nethersole Hospital, Hong Kong, China; 5Drexel University College of Medicine, Philadelphia, PA, USA; 6Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; 7Yong Loo Lin School of Medicine, National University of Singapore; 8Liver Clinic, Surat, India; 9Gilead Sciences Inc., Foster City, CA, USA; 10Toronto General Hospital, Toronto, ON, Canada; 11Toronto Liver Centre, Toronto, ON, Canada; 12San Jose Gastroenterology, San Jose, CA; 13The Chinese University of Hong Kong, Hong Kong SAR, Peoples Republic of China; 14Hopital Beaujon, Universite Paris-Diderot, Clichy, France;
|
| |
|
|
|
|
|
